Search research articles
Contact Us
Filters
Showing results (191-200 of 205) with videos related to
Page
of 21
Sort By:
NPJ Breast Cancer
|
March 18, 2026
Peri-lymphatic cytokines (IRX-2) as immunologic induction preceding neoadjuvant chemo-immunotherapy in triple-negative breast cancer
Alan Su, Erin C Hong, Nicole Moxon, et al.
Gut
|
July 22, 2020
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning
Korsuk Sirinukunwattana, Enric Domingo, Susan D Richman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2019
A Phase Ib Study of Preoperative, Locoregional IRX-2 Cytokine Immunotherapy to Prime Immune Responses in Patients with Early-Stage Breast Cancer
David B Page, Joanna Pucilowska, Katherine G Sanchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 6, 2022
Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinical Data
Natalie C Fisher, Ryan M Byrne, Holly Leslie, et al.
NPJ Breast Cancer
|
June 21, 2023
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer
David B Page, Joanna Pucilowska, Brie Chun, et al.
The Lancet. Oncology
|
August 11, 2022
Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial
Tomoko Yamazaki, Andrew J Gunderson, Miranda Gilchrist, et al.
The Lancet. Oncology
|
April 10, 2018
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
John M Wrangle, Vamsidhar Velcheti, Manish R Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 8, 2020
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer
Sudhir B Malla, David J Fisher, Enric Domingo, et al.
Gut
|
April 28, 2022
Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer
Shania M Corry, Amy Mb McCorry, Tamsin Rm Lannagan, et al.
Nature Communications
|
December 8, 2022
Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features
Dustin J Flanagan, Raheleh Amirkhah, David F Vincent, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 205) with videos related to
Sort By:
Page
of 21
NPJ Breast Cancer
|
March 18, 2026
Peri-lymphatic cytokines (IRX-2) as immunologic induction preceding neoadjuvant chemo-immunotherapy in triple-negative breast cancer
Alan Su, Erin C Hong, Nicole Moxon, et al.
Gut
|
July 22, 2020
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning
Korsuk Sirinukunwattana, Enric Domingo, Susan D Richman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2019
A Phase Ib Study of Preoperative, Locoregional IRX-2 Cytokine Immunotherapy to Prime Immune Responses in Patients with Early-Stage Breast Cancer
David B Page, Joanna Pucilowska, Katherine G Sanchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 6, 2022
Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinical Data
Natalie C Fisher, Ryan M Byrne, Holly Leslie, et al.
NPJ Breast Cancer
|
June 21, 2023
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer
David B Page, Joanna Pucilowska, Brie Chun, et al.
The Lancet. Oncology
|
August 11, 2022
Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial
Tomoko Yamazaki, Andrew J Gunderson, Miranda Gilchrist, et al.
The Lancet. Oncology
|
April 10, 2018
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
John M Wrangle, Vamsidhar Velcheti, Manish R Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 8, 2020
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer
Sudhir B Malla, David J Fisher, Enric Domingo, et al.
Gut
|
April 28, 2022
Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer
Shania M Corry, Amy Mb McCorry, Tamsin Rm Lannagan, et al.
Nature Communications
|
December 8, 2022
Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features
Dustin J Flanagan, Raheleh Amirkhah, David F Vincent, et al.
Page
of 21